skip to main content
Visitante
Meu Espaço
Minha Conta
Sair
Identificação
This feature requires javascript
Tags
Revistas Eletrônicas (eJournals)
Livros Eletrônicos (eBooks)
Bases de Dados
Bibliotecas USP
Ajuda
Ajuda
Idioma:
Inglês
Espanhol
Português
This feature required javascript
This feature requires javascript
Primo Search
Busca Geral
Busca Geral
Acervo Físico
Acervo Físico
Produção Intelectual da USP
Produção USP
Search For:
Clear Search Box
Search in:
Busca Geral
Or hit Enter to replace search target
Or select another collection:
Search in:
Busca Geral
Busca Avançada
Busca por Índices
This feature requires javascript
This feature requires javascript
Androgen deprivation of prostate cancer: Leading to a therapeutic dead end
Katzenwadel, Arndt ; Wolf, Philipp
Cancer letters, 2015-10, Vol.367 (1), p.12-17
[Periódico revisado por pares]
Ireland: Elsevier Ireland Ltd
Texto completo disponível
Citações
Citado por
Exibir Online
Detalhes
Resenhas & Tags
Mais Opções
Nº de Citações
This feature requires javascript
Enviar para
Adicionar ao Meu Espaço
Remover do Meu Espaço
E-mail (máximo 30 registros por vez)
Imprimir
Link permanente
Referência
EasyBib
EndNote
RefWorks
del.icio.us
Exportar RIS
Exportar BibTeX
This feature requires javascript
Título:
Androgen deprivation of prostate cancer: Leading to a therapeutic dead end
Autor:
Katzenwadel, Arndt
;
Wolf, Philipp
Assuntos:
Androgen Antagonists - adverse effects
;
Androgen Antagonists - therapeutic use
;
Androgen deprivation therapy
;
Androgens
;
Animals
;
Antineoplastic Agents, Hormonal - adverse effects
;
Antineoplastic Agents, Hormonal - therapeutic use
;
Cancer therapies
;
Castration resistance
;
Chemotherapy
;
Diabetes
;
Disease Progression
;
Drug Design
;
Drug Resistance, Neoplasm
;
Drugs
;
Gene expression
;
Hematology, Oncology and Palliative Medicine
;
Humans
;
Ligands
;
Male
;
Metastasis
;
Molecular alterations
;
Molecular Targeted Therapy
;
Mortality
;
Neoplasm Recurrence, Local
;
Patients
;
Prostate cancer
;
Prostatic Neoplasms, Castration-Resistant - drug therapy
;
Prostatic Neoplasms, Castration-Resistant - metabolism
;
Prostatic Neoplasms, Castration-Resistant - mortality
;
Prostatic Neoplasms, Castration-Resistant - pathology
;
Proteins
;
Regulatory approval
;
Signal Transduction - drug effects
;
Studies
;
Testosterone
;
Treatment Outcome
;
Tumors
É parte de:
Cancer letters, 2015-10, Vol.367 (1), p.12-17
Notas:
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Descrição:
Highlights • Androgen deprivation therapy (ADT) leads to numerous molecular alterations in prostate cancer. • ADT promotes more aggressive behavior and metastasis of tumor cells. • ADT ends in incurable castration resistant disease. • ADT of advanced prostate cancer leads to a reduced efficacy of anticancer agents. • Therapeutic intervention seems to be indicated before castration resistance occurs.
Editor:
Ireland: Elsevier Ireland Ltd
Idioma:
Inglês
Links
View this record in MEDLINE/PubMed
This feature requires javascript
This feature requires javascript
Voltar para lista de resultados
This feature requires javascript
This feature requires javascript
Buscando em bases de dados remotas. Favor aguardar.
Buscando por
em
scope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
Mostrar o que foi encontrado até o momento
This feature requires javascript
This feature requires javascript